Top Markets
Coin of the day
G&E Herbal Biotechnology Co., Ltd. G&E Herbal Biotechnology Co., Ltd.

G&E Herbal Biotechnology Co., Ltd.

4911
株式のランク #24234
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise,... G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
株価
$0.91899191
最終同期: 2026-08-21
時価総額
$63.24M
変化(1日)
0.17%
変化(1年)
-39.70%
CN
取引 G&E Herbal Biotechnology Co., Ltd. (4911)

カテゴリー

G&E Herbal Biotechnology Co., Ltd.(4911)の収益
Aug 2026 時点の収益 TTM: 0
G&E Herbal Biotechnology Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
G&E Herbal Biotechnology Co., Ltd. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
$12.62B -
US
$6.02B -
NL
$2.23B -
US
$15.70B -
AU
- -
CH